Articles

Search all Rheumatology and Therapy articles

Filter by

Volume:

Sort by

Date published:

New to old Old to new

Showing 1-50 of 669 articles

Projected Health and Economic Burden of Comorbid Gout and Chronic Kidney Disease in a Virtual US Population: A Microsimulation Study
Joshua Card-Gowers
Lise Retat
Laura Webber
Original Research Open access 05 June 2024
Cardiovascular Risk Evaluation in Psoriatic Arthritis by Aortic Stiffness and the Systemic Coronary Risk Evaluation (SCORE): Results of the Prospective PSOCARD Cohort Study
Konstantinos Triantafyllias
Stefanie Liverakos
Andreas Schwarting
Original Research Open access 31 May 2024
Drug Persistence and Incidence of Active Tuberculosis of Tumor Necrosis Factor Alpha Inhibitors Versus Tocilizumab as the First-Line Biological Treatment in Patients with Rheumatoid Arthritis: A Nationwide Population-Based Retrospective Cohort Analysis
Min Wook So
A-Ran Kim
Seung-Geun Lee
Original Research Open access 20 May 2024
Correction: Ixekizumab Efficacy in Patients with Severe Peripheral Psoriatic Arthritis: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (SPIRIT-P1)
Hideto Kameda
Kohei Hagimori
Hiroaki Dobashi
Correction Open access 16 May 2024
Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data
Lars Erik Kristensen
Atul Deodhar
Dafna D. Gladman
Commentary Open access 02 May 2024 Pages: 487 - 499
Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials
Gerd R. Burmester
Jayne Stigler
Lianne S. Gensler
Original Research Open access 29 April 2024 Pages: 737 - 753
Population Pharmacokinetics of the Anti-Interferon-Gamma Monoclonal Antibody Emapalumab: An Updated Analysis
Patrick Brossard
Christian Laveille
Brief Report Open access 25 April 2024 Pages: 869 - 880
Elevating the Standard of Care for Patients with Psoriatic Arthritis: ‘Calls to Action’ from a Multistakeholder Pan-European Initiative
Iris Verbinnen
Emilio Monte-Boquet
Philip S. Helliwell
Original Research Open access 25 April 2024 Pages: 795 - 815
Elevating the Standard of Care for Patients with Axial Spondyloarthritis: ‘Calls to Action’ from Rheumacensus, a Multistakeholder Pan-European Initiative
Andri Phoka
Bart J. F. van den Bemt
Xenofon Baraliakos
Original Research Open access 25 April 2024 Pages: 773 - 794
A Phase 1a Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7303509, an Anti-TGFβ3 Antibody, in Healthy Volunteers
Lyrialle W. Han
Samira Jamalian
Sara Glickstein
Original Research Open access 25 April 2024 Pages: 755 - 771
A Machine Learning Approach for Prediction of CDAI Remission with TNF Inhibitors: A Concept of Precision Medicine from the FIRST Registry
Koshiro Sonomoto
Yoshihisa Fujino
Yoshiya Tanaka
Original Research Open access 18 April 2024 Pages: 709 - 736
Exploring the Effects of Ixekizumab on Pain in Patients with Ankylosing Spondylitis Based on Objective Measures of Inflammation: Post Hoc Analysis from a Large Randomized Clinical Trial
Kurt de Vlam
Walter P. Maksymowych
Philip G. Conaghan
Original Research Open access 18 April 2024 Pages: 691 - 707
Efficacy and Safety of Secukinumab in US Patients with Psoriatic Arthritis: A Subgroup Analysis of the Phase 3 FUTURE Studies
Alan J. Kivitz
Joel M. Kremer
Atul Singhal
Original Research Open access 16 April 2024 Pages: 675 - 689
Clinical Characteristics of “Severe” Peripheral Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort
Ennio Lubrano
Silvia Scriffignano
Fabio Massimo Perrotta
Original Research Open access 09 April 2024 Pages: 663 - 674
Current Use and Barriers to Point-of-Care Ultrasound in Rheumatology: A National Survey of VA Medical Centers
Ayesha Iqbal
Madiha Ahmad
Nilam J. Soni
Brief Report Open access 06 April 2024 Pages: 855 - 867
Characteristics and 6-Month Outcomes in Patients with Rheumatoid Arthritis Initiating Infliximab Biosimilar IFX-dyyb in a Real-World Setting
Joshua F. Baker
Catherine Bakewell
Karim R. Masri
Brief Report Open access 20 March 2024 Pages: 841 - 853
Long-Term Efficacy Following Intra-articular Injection of Carboxymethyl-chitosan, a New Product Class for Knee Osteoarthritis: Results from an Observational Study in Germany
Nils A. Lynen
Christoph Eichhorn
Wim Weyenberg
Original Research Open access 18 March 2024 Pages: 649 - 662
Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the KEEPsAKE 2 Randomized Clinical Trial
Andrew Östör
Filip Van den Bosch
Alan Kivitz
Original Research Open access 18 March 2024 Pages: 633 - 648
Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the Phase 3 KEEPsAKE 1 Randomized Clinical Trial
Lars Erik Kristensen
Mauro Keiserman
Frank Behrens
Original Research Open access 18 March 2024 Pages: 617 - 632
Long-term Efficacy and Safety Following Switch Between Upadacitinib and Adalimumab in Patients with Rheumatoid Arthritis: 5-Year Data from SELECT-COMPARE
Roy Fleischmann
Ricardo Blanco
Eduardo Mysler
Original Research Open access 18 March 2024 Pages: 599 - 615
Comparative Effectiveness of Bimekizumab and Guselkumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison
Richard B. Warren
Iain B. McInnes
Philip J. Mease
Brief Report Open access 15 March 2024 Pages: 829 - 839
Long-term Etanercept Response for Patients with Radiographic Axial Spondyloarthritis Based on Achievement of Early, Intermediate, or Late Responses During Index Studies
Xenofon Baraliakos
Annette E. Szumski
Cecilia E. Borlenghi
Original Research Open access 15 March 2024 Pages: 583 - 597
Real-World Effectiveness of Upadacitinib for Treatment of Rheumatoid Arthritis in Canadian Patients: Interim Results from the Prospective Observational CLOSE-UP Study
Louis Bessette
Jonathan Chan
Derek Haaland
Original Research Open access 11 March 2024 Pages: 563 - 582
Comparative Effectiveness of Bimekizumab and Secukinumab in Patients with Psoriatic Arthritis at 52 Weeks Using a Matching-Adjusted Indirect Comparison
Philip J. Mease
Richard B. Warren
Iain B. McInnes
Brief Report Open access 06 March 2024 Pages: 817 - 828
Assessment of Patient–Physician Interactions in Psoriatic Arthritis: National Results of the ASSIST Study
Fabio Massimo Perrotta
Rossana Scrivo
Ennio Lubrano
Original Research Open access 06 March 2024 Pages: 553 - 562
The Evaluation of Effectiveness and Safety of Guselkumab in Patients with Psoriatic Arthritis in a Prospective Multicentre “Real-Life” Cohort Study
Piero Ruscitti
Giulia Cataldi
Paola Cipriani
Original Research Open access 04 March 2024 Pages: 539 - 551
Treatment Persistence and Switching Patterns of Adalimumab Biosimilar ABP 501 in European Patients with Rheumatologic Diseases
Ran Jin
Silvia Kruppert
Jonathan Kay
Original Research Open access 04 March 2024 Pages: 523 - 537
Neutrophilic Activity Biomarkers (Plasma Neutrophil Extracellular Traps and Calprotectin) in Established Patients with Rheumatoid Arthritis Receiving Biological or JAK Inhibitors: A Clinical and Ultrasonographic Study
Beatriz Frade-Sosa
Andrés Ponce
Raimon Sanmarti
Original Research Open access 02 March 2024 Pages: 501 - 521
Comparing Efficacy of Guselkumab versus Ustekinumab in Patients with Psoriatic Arthritis: An Adjusted Comparison Using Individual Patient Data from the DISCOVER and PSUMMIT Trials
Pushpike Thilakarathne
Agata Schubert
Fareen Hassan
Original Research Open access 28 February 2024 Pages: 457 - 474
Use of Apremilast to Achieve Psoriatic Arthritis Treatment Goals and Satisfaction at 1 Year in the Canadian Real-World APPRAISE Study
Vinod Chandran
Louis Bessette
John S. Sampalis
Original Research Open access 28 February 2024 Pages: 443 - 455
Work Productivity and General Health Through 2 Years of Guselkumab Treatment in a Phase 3 Randomized Trial of Patients With Active Psoriatic Arthritis
Jeffrey R. Curtis
Iain B. McInnes
Philip J. Mease
Original Research Open access 22 February 2024 Pages: 425 - 441
Reproductive Effect by Rheumatoid Arthritis and Related Autoantibodies
Ping-Fen Li
Shan Li
Peng-Sheng Zheng
Review Open access 20 February 2024 Pages: 239 - 256
Reliability Exercise of Ultrasound Salivary Glands in Sjögren’s Disease: An International Web Training Initiative
Baptiste Quéré
Alain Saraux
Sandrine Jousse-Joulin
Original Research Open access 19 February 2024 Pages: 411 - 423
Thermography at the Elbow Among Patients with Rheumatoid Arthritis: A Comparison with Ultrasound-Detected Joint Inflammation Findings
York Kiat Tan
Rehena Sultana
Julian Thumboo
Brief Report Open access 15 February 2024 Pages: 475 - 485
Anemia and Low Body Mass Index in Axial Spondyloarthritis: Results from ChinaSpA, the Chinese Spondyloarthritis Registry
Hailong Li
Qingyang Li
Xiang Gao
Original Research Open access 13 February 2024 Pages: 397 - 409
Safety and Efficacy of Hybrid Cooperative Complexes of Sodium Hyaluronate and Sodium Chondroitin for the Treatment of Patients with Symptomatic Knee Osteoarthritis
Cristiano Sconza
Dario Romano
Berardo Di Matteo
Original Research Open access 12 February 2024 Pages: 381 - 395
Real-World Use and Effectiveness Outcomes in Patients with Rheumatoid Arthritis Treated with Upadacitinib: An Analysis from the CorEvitas Registry
Joshua F. Baker
Patrick Zueger
Robert R. McLean
Original Research Open access 12 February 2024 Pages: 363 - 380
Emerging Role of Interleukin-38 (IL-38) in the Development of Rheumatoid Arthritis
Shengxiang Liang
Liting Chen
Min Yang
Original Research Open access 05 February 2024 Pages: 349 - 362
Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE
Eugen Feist
Xenofon Baraliakos
Thomas Meng
Original Research Open access 03 February 2024 Pages: 331 - 348
Efficacy and Safety of Risankizumab in Patients with Psoriatic Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Qin-Yi Su
Hao-Nan Zhou
Sheng-Xiao Zhang
Review Open access 01 February 2024 Pages: 227 - 237
Effectiveness of Tofacitinib in Patients Initiating Therapy for Psoriatic Arthritis: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Philip J. Mease
Pamela Young
Alexis Ogdie
Original Research Open access 22 January 2024 Pages: 313 - 329
Social Listening in Gout: Impact of Proactive vs. Reactive Management on Self-Reported Emotional States
Maurice Flurie
Monica Converse
Maria Picone
Original Research Open access 22 January 2024 Pages: 301 - 311
The Impact of Systemic Lupus Erythematosus Flares on Clinical and Economic Outcomes: The CHAMOMILE Claims Database Study in Germany
Bo Ding
Marc Pignot
Andreas Schwarting
Original Research Open access 22 January 2024 Pages: 285 - 299
Plasma Proteomic Analysis Based on 4D-DIA Evaluates the Clinical Response to Imrecoxib in the Early Treatment of Osteoarthritis
Han Xie
Yuan Zhang
Weihong Ge
Original Research Open access 18 January 2024 Pages: 269 - 283
Impact of the COVID-19 Pandemic on People Living with Rheumatoid Arthritis: Experiences and Preferences in Accessing Healthcare Across Five Countries
Alain Saraux
Licia Maria Henrique da Mota
Meriem Kessouri
Original Research Open access 13 January 2024 Pages: 257 - 268
Characteristics of COVID-19 and Impact of Disease Activity in Patients with Adult-Onset Still’s Disease
Xinyue Hong
Xiaoming Wang
Huihui Chi
Brief Report Open access 06 January 2024 Pages: 201 - 212
Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years
Christina Charles-Schoeman
Jon T. Giles
Iain B. McInnes
Original Research Open access 05 January 2024 Pages: 157 - 175
Safety and Efficacy of Inactivated SARS-CoV-2 Vaccine in Patients with Rheumatic Diseases and Serum Antibody Changes Post-Omicron Variant Infection
Xiaowei Zhang
Yifei Li
Guihong Wang
Brief Report Open access 04 January 2024 Pages: 191 - 200
The Role of Early Treatment in the Management of Axial Spondyloarthritis: Challenges and Opportunities
Daniele Mauro
Giulio Forte
Francesco Ciccia
Review Open access 18 December 2023 Pages: 19 - 34
Adalimumab Effectively Decreases Inflammation Downstream of TNFα Signaling in Synoviocytes from Extended Oligoarticular Juvenile Idiopathic Arthritis
Megan M. Simonds
Samuel T. Freer
AnneMarie C. Brescia
Original Research Open access 09 December 2023 Pages: 143 - 155

1
2
…
14
Next page